About
Symic Bio develops therapeutics for fibrotic diseases by targeting the extracellular matrix to modify disease progression.
Explore Symic Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.
Symic Bio develops therapeutics for fibrotic diseases by targeting the extracellular matrix to modify disease progression.
Funding rounds, investor list, and risk signals — unlock with a subscription.